Medical Benefit, Hospital Drugs Exempt From Detailed Cost, Coverage Reporting In Final Rule
The most detailed US reporting requirements regarding prescription drug costs and coverage will target medicines reimbursed under the retail pharmacy benefit.
You may also be interested in...
Institute for Clinical and Economic Review analysis of whether payers are providing “fair access” to fairly priced drugs was hampered by a lack of transparency among payers, leading to calls for reform.
Score of slimmed down Medicare negotiations in the Build Back Better legislation is $79bn, a far cry from the $456bn in savings projected from the draconian HR 3. But the bill’s overall impact on the deficit means that pharma might get a total reprieve – or go back on the chopping block.
Annual Business Group on Health survey on employer-sponsored insurance covers pricing reform, rebate model alternatives, paying for high-cost drugs and copay coupons.